GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: AZ-13337019 | AZ13337019 | Movantik® | Moventig® | NKTR-118
naloxegol is an approved drug (EMA & FDA (2014))
Compound class:
Synthetic organic
Comment: Naloxegol is a PEGylated version of naloxol (α-naloxol PubChem CID 5492271; β-naloxol PubChem CID 5492293). PEGylation reduces the compound's ability to cross the blood-brain barrier, therefore restricting CNS penetration. Naloxegol is termed a peripherally acting μ-opioid receptor antagonist, or PAMORA. The synonyms suffixed with "oxalate " map to the salt as PubChem CID 56959086
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. EU EMA (2014) | US FDA (2014) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9434 | naloxegol |
Synonyms ![]() |
| AZ-13337019 | AZ13337019 | Movantik® | Moventig® | NKTR-118 |
Database Links ![]() |
|
| CAS Registry No. | 854601-70-0 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL2219418 |
| DrugCentral Ligand | 4832 |
| GtoPdb PubChem SID | 187051840 |
| PubChem CID | 56959087 |
| Search Google for chemical match using the InChIKey | XNKCCCKFOQNXKV-ZRSCBOBOSA-N |
| Search Google for chemicals with the same backbone | XNKCCCKFOQNXKV |
| Search PubMed clinical trials | naloxegol |
| Search PubMed titles | naloxegol |
| Search PubMed titles/abstracts | naloxegol |
| UniChem Compound Search for chemical match using the InChIKey | XNKCCCKFOQNXKV-ZRSCBOBOSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | XNKCCCKFOQNXKV-ZRSCBOBOSA-N |
| Wikipedia | Naloxegol |